Short answer
Embrace continuous manufacturing principles to design more agile, cost-effective, and high-quality pharmaceutical production systems.
- Field
- Commercial Production
- Source
- Annual Review of Chemical and Biomolecular Engineering (2018)
- Method
- Literature Review
- Evidence
- Strong effect
Transitioning from batch to continuous manufacturing in pharmaceuticals offers significant advantages in development speed, cost efficiency, and quality assurance. This commercial production research insight is drawn from a 2018 study published in Annual Review of Chemical and Biomolecular Engineering. Using Literature review, researchers explored how this design variable affects real-world outcomes. The key design takeaway: Embrace continuous manufacturing principles to design more agile, cost-effective, and high-quality pharmaceutical production systems.
Continuous Manufacturing Accelerates Pharmaceutical Development and Reduces Costs
Transitioning from batch to continuous manufacturing in pharmaceuticals offers significant advantages in development speed, cost efficiency, and quality assurance.
Annual Review of Chemical and Biomolecular Engineering · 2018
Key Findings
- 01Continuous manufacturing is encouraged by regulatory bodies.
- 02Key benefits include cost reduction and decreased development cycles.
- 03Enables access to new chemistries not practical in batch processes.
- 04Improves safety and provides flexible manufacturing platforms.
- 05Enhances product quality assurance.
Application
Design takeaway
Embrace continuous manufacturing principles to design more agile, cost-effective, and high-quality pharmaceutical production systems.
How to apply
When designing new pharmaceutical manufacturing processes or upgrading existing ones, evaluate the feasibility and benefits of implementing continuous flow methodologies.
Project actions
- 01Consider how a continuous process could improve an existing product's manufacturing.
- 02Research specific technologies that enable continuous pharmaceutical manufacturing.
Method & Evidence
Variables
Strengths & Limitations
Strengths
- +Comprehensive overview of a significant industry trend.
- +Highlights multiple benefits driving adoption.
Limitations
The complexity of scaling up continuous processes and the initial capital investment can be significant barriers.
Reliability & validity
The review's reliability is based on the synthesis of published literature. Validity is supported by the consensus of findings across multiple sources and the authors' expertise in the field.
Think critically
To what extent do the regulatory bodies truly drive innovation in continuous manufacturing, or are they primarily reacting to industry advancements?
Design Principles
"Agile and integrated manufacturing processes lead to faster innovation and improved product realization."
This shift enables faster market entry for new therapies and allows for the exploration of novel chemical syntheses previously impractical. It also leads to more robust and consistent product quality, a critical factor in the pharmaceutical sector.
What This Means for Your Design
Making drugs in a continuous flow, like a factory assembly line, is better than making them in batches because it's faster, cheaper, safer, and makes the medicine more consistent.
How to use in your project
- 1.Use this research to justify the selection of a continuous manufacturing approach for a pharmaceutical design project, highlighting its advantages over batch processing.
Add to My Project
Quick Cite
Paragraph starter
The transition to continuous manufacturing in the pharmaceutical sector, driven by regulatory support and the pursuit of cost reduction and enhanced quality assurance, presents a paradigm shift from traditional batch processing. This approach offers significant advantages, including decreased development cycles, access to novel chemistries, improved safety, and flexible manufacturing platforms, ultimately leading to more efficient and reliable production of both active pharmaceutical ingredients and final drug products.
Source
Annual Review of Chemical and Biomolecular Engineering
Continuous Manufacturing in Pharmaceutical Process Development and Manufacturing
journal · 2018
View sourceQuestions About This Research
- What does the research say about continuous manufacturing accelerates pharmaceutical development and reduces costs?
- Embrace continuous manufacturing principles to design more agile, cost-effective, and high-quality pharmaceutical production systems. Evidence: Annual Review of Chemical and Biomolecular Engineering (2018).
- Why does "Continuous Manufacturing Accelerates Pharmaceutical Development and Reduces Costs" matter for design?
- This shift enables faster market entry for new therapies and allows for the exploration of novel chemical syntheses previously impractical. It also leads to more robust and consistent product quality, a critical factor in the pharmaceutical sector.
- How can designers apply this research?
- Embrace continuous manufacturing principles to design more agile, cost-effective, and high-quality pharmaceutical production systems.
- What were the main findings?
- Continuous manufacturing is encouraged by regulatory bodies.. Key benefits include cost reduction and decreased development cycles.. Enables access to new chemistries not practical in batch processes.. Improves safety and provides flexible manufacturing platforms.
- What research method was used?
- Literature Review.
- How strong is the evidence?
- Evidence strength is rated Strong effect, based on a 2018 journal from Annual Review of Chemical and Biomolecular Engineering.
- What should I do differently in my next project?
- When designing new pharmaceutical manufacturing processes or upgrading existing ones, evaluate the feasibility and benefits of implementing continuous flow methodologies.
- What are the limitations?
- The review is primarily focused on small, chemically synthesized organic molecules and does not extensively cover biologics or other complex therapeutic modalities.